Expression of p53, p21 and bcl 2 in patients with cryptogenic organizing pneumonia

M. Plataki, A. V. Koutsopoulos, H. Tzortzaki, C. Dambaki, K. Darivianaki, E. Stathopoulos, B. Demosthenes, N. M. Siafakas (Heraklion, Alexandroupolis, Greece)

Source: Annual Congress 2005 - Miscellaneous diffuse parenchymal lung disease
Session: Miscellaneous diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 3497
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Plataki, A. V. Koutsopoulos, H. Tzortzaki, C. Dambaki, K. Darivianaki, E. Stathopoulos, B. Demosthenes, N. M. Siafakas (Heraklion, Alexandroupolis, Greece). Expression of p53, p21 and bcl 2 in patients with cryptogenic organizing pneumonia. Eur Respir J 2005; 26: Suppl. 49, 3497

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of the Bcl-2 binding protein beclin 1 in human idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Expression of survivin and p53 protein in pulmonary tumours
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011

High expression apoptotic proteins; P53, FAS, and BAX associated with down regulation of BCL-2 in tuberculosis granulomas: an immunohistochemistry study
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005

Differences in expression of apoptosis regulatory proteins in idiopathic pulmonary fibrosis and cryptogenic organizing pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 306s
Year: 2006

Apoptosis regulatory protein (p53, Bcl-2, survivin) expression in lung cancer-preliminary study
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Downregulation of the pro-apototic gene, BNIPL, in bronchial biopsies from COPD patients
Source: ERS Lung Science Conference 2017
Year: 2017

Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis
Source: Eur Respir J 2001; 18: Suppl. 33, 230s
Year: 2001

Time dependent expression of bcl-2 and bax genes in lung cells of septic rats
Source: Eur Respir J 2001; 18: Suppl. 33, 198s
Year: 2001

RNA-binding protein HuR inhibits the expression of sirtuin-1 in patients with COPD
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Polymorphisms in the p53 and p21 promoter are associated with susceptibility to COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 52s
Year: 2005

Soluble form of CD95 (Fas/Apo-1) in patients with community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 320s
Year: 2004

Expression profiles of inhibitory of growth family member 4 (ING4) in different forms of pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

The role of HER-2/neu, p53, Bcl-2 and Ki-67 in patients with lung cancer
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019

Immunohistochemical expression of Bcl-2 and p53 in patients with lung cancer: Correlation with survival time
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Studies on clinical significance and relationship with PI and gene protein expression of p16, Rb and Cyclin-D1 in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002

Immunohistocemical expression of P53 and BCL-2 in pateints with lung cancer: correlation with survival time
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

Homeodomain-interracting protein kinase 2 (HIPK2) in idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010


Estimation of activity apoptosis genes based on expression of Bcl2, Bax, CPP32 in bronchial epithelium in asthma
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010

MDM2 gene amplification and mdm2 protein expression in NSCLC cells
Source: Eur Respir J 2005; 26: Suppl. 49, 91s
Year: 2005

Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013